Kalle Hoppu

4.1k total citations
82 papers, 2.7k citations indexed

About

Kalle Hoppu is a scholar working on Pediatrics, Perinatology and Child Health, Pharmacology and Transplantation. According to data from OpenAlex, Kalle Hoppu has authored 82 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Pediatrics, Perinatology and Child Health, 18 papers in Pharmacology and 14 papers in Transplantation. Recurrent topics in Kalle Hoppu's work include Pharmaceutical studies and practices (22 papers), Pharmacological Effects and Toxicity Studies (21 papers) and Antibiotics Pharmacokinetics and Efficacy (16 papers). Kalle Hoppu is often cited by papers focused on Pharmaceutical studies and practices (22 papers), Pharmacological Effects and Toxicity Studies (21 papers) and Antibiotics Pharmacokinetics and Efficacy (16 papers). Kalle Hoppu collaborates with scholars based in Finland, United States and Sweden. Kalle Hoppu's co-authors include Pirkko Santavuori, Mirja Hämäläinen, Maija Pohjavuori, Harri Saxén, Christer Holmberg, Gerard F. Cooney, A. Nergårdh, Heikki Rantala, Mikko Hallman and Janne T. Backman and has published in prestigious journals such as New England Journal of Medicine, The Lancet and PLoS ONE.

In The Last Decade

Kalle Hoppu

81 papers receiving 2.5k citations

Peers

Countries citing papers authored by Kalle Hoppu

Since Specialization

Citations

This map shows the geographic impact of Kalle Hoppu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kalle Hoppu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kalle Hoppu more than expected).

Fields of papers citing papers by Kalle Hoppu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kalle Hoppu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kalle Hoppu. The network helps show where Kalle Hoppu may publish in the future.

Co-authorship network of co-authors of Kalle Hoppu

This figure shows the co-authorship network connecting the top 25 collaborators of Kalle Hoppu. A scholar is included among the top collaborators of Kalle Hoppu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kalle Hoppu. Kalle Hoppu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Essential medicines for children 2015 ·Archives of Disease in Childhood ·Kalle Hoppu, Shalini Sri Ranganathan	11
2	First Dose in Neonates: Are Juvenile Mice, Adults and In Vitro–In Silico Data Predictive of Neonatal Pharmacokinetics of Fluconazole 2014 ·Clinical Pharmacokinetics ·Wei Zhao, Chantal Le Guellec, Daniel K. Benjamin, William Hope, (unknown), Kevin Watt, Johannes N. van den Anker, Boris Matrot, Harri Saxén, Kalle Hoppu, Paolo Manzoni, Évelyne Jacqz-Aigrain	15
3	Reflection: medicines for children—science alone is not enough 2013 ·European Journal of Clinical Pharmacology ·Kalle Hoppu	5
4	Position paper update: gastric lavage for gastrointestinal decontamination 2013 ·Clinical Toxicology ·(unknown), Kalle Hoppu, William G. Troutman, R. Bédry, Andrew R. Erdman, (unknown), Bruno Mégarbane, Ruben Thanacoody, E. Martin Caravati	120
5	Realities of paediatric pharmacotherapy in the developing world 2011 ·Archives of Disease in Childhood ·Kalle Hoppu, Shalini Sri Ranganathan, Alexander Dodoo	20
6	Application of the Optimal Design Approach to Improve a Pretransplant Drug Dose Finding Design for Ciclosporin 2011 ·The Journal of Clinical Pharmacology ·Stefanie Hennig, Joakim Nyberg, (unknown), Janne T. Backman, Kalle Hoppu, Andrew C. Hooker, Mats O. Karlsson	17
7	Evolution of paediatric off‐label use after new significant medicines become available for adults: a study on triptans in Finnish children 1994–2007 2010 ·British Journal of Clinical Pharmacology ·(unknown), Marja Airaksinen, Ann Marie Kaukonen, Timo Klaukka, Kalle Hoppu	10
8	Long‐Term Changes in Cyclosporine Pharmacokinetics After Renal Transplantation in Children: Evidence for Saturable Presystemic Metabolism and Effect ofNR1I2Polymorphism 2010 ·The Journal of Clinical Pharmacology ·(unknown), Siv Jönsson, Mats O. Karlsson, Mikko Niemi, Christer Holmberg, Kalle Hoppu, Janne T. Backman	25
9	Medication errors made by health care professionals. Analysis of the Finnish Poison Information Centre data between 2000 and 2007 2008 ·European Journal of Clinical Pharmacology ·Tapio Kuitunen, (unknown), Kalle Hoppu	14
10	First-order alcohol elimination in severe alcohol intoxication in an adolescent: a case report 2008 ·The American Journal of Emergency Medicine ·Anne Lamminpää, Kalle Hoppu	5
11	Developmental pharmacokinetics of ciclosporin – a population pharmacokinetic study in paediatric renal transplant candidates 2007 ·British Journal of Clinical Pharmacology ·(unknown), Siv Jönsson, Janne T. Backman, Mats O. Karlsson, Kalle Hoppu	61
12	Paediatric clinical pharmacology—at the beginning of a new era 2007 ·European Journal of Clinical Pharmacology ·Kalle Hoppu	42
13	Predictive value of pretransplantation cyclosporine pharmacokinetic studies on initial post‐transplantation dosing in pediatric kidney allograft recipients 2003 ·Pediatric Transplantation ·(unknown), Kalle Hoppu, Hannu Jalanko, Christer Holmberg	4
14	Focusing on changing clinical practice to enhance rational prescribing—collaboration and networking enable comprehensive approaches 2003 ·Health Policy ·Arja Helin‐Salmivaara, Risto Huupponen, (unknown), Kalle Hoppu	15
15	KIDNEY FUNCTION AFTER 1:1 CONVERSION TO THE CYCLOSPORINE MICROEMULSION FORMULATION IN CHILDREN WITH LIVER ALLOGRAFTS 1997 ·Transplantation ·Jarmo Laine, Kalle Hoppu, (unknown), (unknown), (unknown)	8
16	Methylprednisolone Exposure, Rather than Dose, Predicts Adrenal Suppression and Growth Inhibition in Children with Liver and Renal Transplants¹ 1997 ·The Journal of Clinical Endocrinology & Metabolism ·Seppo Sarna, Kalle Hoppu, Pertti J. Neuvonen, Jarmo Laine, Christer Holmberg	30
17	COMPARISON OF CONVENTIONAL ORAL CYCLOSPORINE AND CYCLOSPORINE MICROEMULSION FORMULATIONS IN CHILDREN WITH A LIVER TRANSPLANT 1996 ·Transplantation ·Kalle Hoppu, (unknown), Jarmo Laine, Christer Holmberg	20
18	Flunarizine of limited value in children with intractable epilepsy 1995 ·Pediatric Neurology ·Kalle Hoppu, Arne Nergårdh, (unknown), Olof Beck, (unknown), Lars O. Boréus	7
19	Pharmacokinetically determined cyclosporine dosage in young children 1991 ·Pediatric Nephrology ·Kalle Hoppu, Olli Koskimies, Christer Holmberg, (unknown)	44
20	Surfactant proteins in the diagnosis of fetal lung maturity 1989 ·American Journal of Obstetrics and Gynecology ·Mikko Hallman, Pirkko Arjomaa, Kalle Hoppu, Kari Teramo, Toyoaki Akino	19

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact